Menopausal Impact on Skin Aging Among Egyptian Women
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dermoscopy.
- Who it may be relevant to
- Registry conditions: Skin Aging. Basic parameters: 40 years — 60 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Menopausal Impact on Skin Aging Among Egyptian Women: a Comparative Cross-sectional Study
Overview
The goal of this study is to understand how menopause affects skin aging in Egyptian women between the ages of 40 and 60. The main question the study wants to answer is: Does menopause cause any changes in how the skin ages? To find out, the participants will be divided into two groups based on their menstrual history: * Women who have not yet gone through menopause (premenopausal) * Women who have already gone through menopause (postmenopausal) A researcher will examine the skin of women in both groups to look for signs of aging. Then, the results will be compared to see if there are any differences between the two groups.
Interventions
- Device Dermoscopy
dermoscopic assessment of skin aging signs
Primary outcome measures
- Clinical skin aging severity using Glogau Photoaging Scale [Time frame: Assessed once at baseline during participant's visit]
- Dermoscopic skin aging score using the dermoscopic photoaging assessment scale [Time frame: Assessed once at baseline during participant 's visit]
Secondary outcome measures (3)
- Prevalence of specific clinical and dermoscopic aging features [Time frame: Recorded during clinical and dermoscopic assessment at baseline]
- Correlation between menopausal status and severity of skin aging [Time frame: Assessed once at baseline during participant's visit based on menopausal history and skin aging scores]
- Correlation between menopausal duration and skin aging [Time frame: Menopausal duration collected via history at baseline; skin aging assessed at baseline]
Eligibility criteria
Inclusion criteria
- Females aged 40 to 60 years
- Egyptian nationality or residency
- Ability to provide informed consent
- Classified as either:
- Premenopausal (still menstruating regularly)
- Postmenopausal (no menstruation for ≥12 months)
Exclusion criteria
- Menopausal transition (Perimenopausal women
- Menopause induced by hysterectomy
- History of hormone therapy in the past 6 months
- Active dermatological conditions affecting the face (e.g. eczema, psoriasis)
- Use of anti-aging skin treatments (e.g. laser, fillers, retinoids)
- Severe chronic illnesses that may affect skin condition
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-control
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07120542 · Soh-Med--25-7-1MS